Cargando…
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077988/ https://www.ncbi.nlm.nih.gov/pubmed/27049916 http://dx.doi.org/10.18632/oncotarget.7454 |
_version_ | 1782462282981179392 |
---|---|
author | Bougnaud, Sébastien Golebiewska, Anna Oudin, Anaïs Keunen, Olivier Harter, Patrick N. Mäder, Lisa Azuaje, Francisco Fritah, Sabrina Stieber, Daniel Kaoma, Tony Vallar, Laurent Brons, Nicolaas H.C. Daubon, Thomas Miletic, Hrvoje Sundstrøm, Terje Herold-Mende, Christel Mittelbronn, Michel Bjerkvig, Rolf Niclou, Simone P. |
author_facet | Bougnaud, Sébastien Golebiewska, Anna Oudin, Anaïs Keunen, Olivier Harter, Patrick N. Mäder, Lisa Azuaje, Francisco Fritah, Sabrina Stieber, Daniel Kaoma, Tony Vallar, Laurent Brons, Nicolaas H.C. Daubon, Thomas Miletic, Hrvoje Sundstrøm, Terje Herold-Mende, Christel Mittelbronn, Michel Bjerkvig, Rolf Niclou, Simone P. |
author_sort | Bougnaud, Sébastien |
collection | PubMed |
description | The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we show that patient-derived glioblastoma xenografts generated in the mouse brain from organotypic spheroids reproducibly give rise to three different histological phenotypes: (i) a highly invasive phenotype with an apparent normal brain vasculature, (ii) a highly angiogenic phenotype displaying microvascular proliferation and necrosis and (iii) an intermediate phenotype combining features of invasion and vessel abnormalities. These phenotypic differences were visible during early phases of tumour development suggesting an early instructive role of tumour cells on the brain parenchyma. Conversely, we found that tumour-instructed stromal cells differentially influenced tumour cell proliferation and migration in vitro, indicating a reciprocal crosstalk between neoplastic and non-neoplastic cells. We did not detect any transdifferentiation of tumour cells into endothelial cells. Cell type-specific transcriptomic analysis of tumour and endothelial cells revealed a strong phenotype-specific molecular conversion between the two cell types, suggesting co-evolution of tumour and endothelial cells. Integrative bioinformatic analysis confirmed the reciprocal crosstalk between tumour and microenvironment and suggested a key role for TGFβ1 and extracellular matrix proteins as major interaction modules that shape glioblastoma progression. These data provide novel insight into tumour-host interactions and identify novel stroma-specific targets that may play a role in combinatorial treatment strategies against glioblastoma. |
format | Online Article Text |
id | pubmed-5077988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-50779882016-10-28 Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma Bougnaud, Sébastien Golebiewska, Anna Oudin, Anaïs Keunen, Olivier Harter, Patrick N. Mäder, Lisa Azuaje, Francisco Fritah, Sabrina Stieber, Daniel Kaoma, Tony Vallar, Laurent Brons, Nicolaas H.C. Daubon, Thomas Miletic, Hrvoje Sundstrøm, Terje Herold-Mende, Christel Mittelbronn, Michel Bjerkvig, Rolf Niclou, Simone P. Oncotarget Research Paper The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we show that patient-derived glioblastoma xenografts generated in the mouse brain from organotypic spheroids reproducibly give rise to three different histological phenotypes: (i) a highly invasive phenotype with an apparent normal brain vasculature, (ii) a highly angiogenic phenotype displaying microvascular proliferation and necrosis and (iii) an intermediate phenotype combining features of invasion and vessel abnormalities. These phenotypic differences were visible during early phases of tumour development suggesting an early instructive role of tumour cells on the brain parenchyma. Conversely, we found that tumour-instructed stromal cells differentially influenced tumour cell proliferation and migration in vitro, indicating a reciprocal crosstalk between neoplastic and non-neoplastic cells. We did not detect any transdifferentiation of tumour cells into endothelial cells. Cell type-specific transcriptomic analysis of tumour and endothelial cells revealed a strong phenotype-specific molecular conversion between the two cell types, suggesting co-evolution of tumour and endothelial cells. Integrative bioinformatic analysis confirmed the reciprocal crosstalk between tumour and microenvironment and suggested a key role for TGFβ1 and extracellular matrix proteins as major interaction modules that shape glioblastoma progression. These data provide novel insight into tumour-host interactions and identify novel stroma-specific targets that may play a role in combinatorial treatment strategies against glioblastoma. Impact Journals LLC 2016-03-25 /pmc/articles/PMC5077988/ /pubmed/27049916 http://dx.doi.org/10.18632/oncotarget.7454 Text en Copyright: © 2016 Bougnaud et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Bougnaud, Sébastien Golebiewska, Anna Oudin, Anaïs Keunen, Olivier Harter, Patrick N. Mäder, Lisa Azuaje, Francisco Fritah, Sabrina Stieber, Daniel Kaoma, Tony Vallar, Laurent Brons, Nicolaas H.C. Daubon, Thomas Miletic, Hrvoje Sundstrøm, Terje Herold-Mende, Christel Mittelbronn, Michel Bjerkvig, Rolf Niclou, Simone P. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title | Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title_full | Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title_fullStr | Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title_full_unstemmed | Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title_short | Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
title_sort | molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077988/ https://www.ncbi.nlm.nih.gov/pubmed/27049916 http://dx.doi.org/10.18632/oncotarget.7454 |
work_keys_str_mv | AT bougnaudsebastien molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT golebiewskaanna molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT oudinanais molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT keunenolivier molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT harterpatrickn molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT maderlisa molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT azuajefrancisco molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT fritahsabrina molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT stieberdaniel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT kaomatony molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT vallarlaurent molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT bronsnicolaashc molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT daubonthomas molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT miletichrvoje molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT sundstrømterje molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT heroldmendechristel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT mittelbronnmichel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT bjerkvigrolf molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma AT niclousimonep molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma |